Mike Ralston, CEO of Blencowe Resources, explains the significance of the MSP for Orom-Cross. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 378.00
Bid: 377.80
Ask: 378.00
Change: -1.90 (-0.50%)
Spread: 0.20 (0.053%)
Open: 380.70
High: 380.80
Low: 375.30
Prev. Close: 379.90

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

23 Jun 2020 18:11

RNS Number : 8535Q
Marks & Spencer Group PLC
23 June 2020
 

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that on 23 June 2020 it was notified of the following transactions in the Company's Ordinary 25p shares undertaken by director / persons discharging managerial responsibility ('PDMRs'):

1. Performance Share Plan

Exercise of an award granted on 5 December 2016 under the Company's 2016 Performance Share Plan ('PSP'), of which 34% vested as disclosed in the Company's 2018/19 Annual Report and Accounts, and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

2. Deferred Share Bonus Plan

Exercise of awards granted on 23 June 2017 under the Company's 2017 Deferred Share Bonus Plan ('DSBP') and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

3. Restricted Share Plan

Exercise of an award granted on 18 June 2018 under the Company's Restricted Share Plan ('RSP'), of which 50% vested in June 2019 and 50% vested in June 2020, and subsequent sale of shares to satisfy the tax and National Insurance liabilities arising as set out below.

 

PDMR

 

 

Shares exercised on 23 June 2020

Shares sold to cover tax and NI

Shares retained by individual

S Rowe

287,118*

135,421

151,697

S Berendji

40,314

19,016

21,298

P Friston

40,314

19,015

21,299

S Machin

39,452

18,609

20,843

*196,374 shares exercised under 2016 Performance Share Plan and 90,744 shares exercised under 2017 Deferred Share Bonus Plan.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1. Performance Share Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Rowe

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 196,374 shares from the 2016 Performance Share Plan.

2. Subsequent sale of 92,621 shares acquired under the PSP award to cover the tax and NI liability, with 103,753 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

196,374

2. Sale

Price(s)

Volume(s)

£1.1002

92,621

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

196,374

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.1002

92,621

 £101,901.62

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

2. Deferred Share Bonus Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Rowe

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 90,744 shares from the 2017 Deferred Share Bonus Plan.

2. Subsequent sale of 42,800 shares acquired under the DSBP award to cover the tax and NI liability, with 47,944 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

90,744

2. Sale

Price(s)

Volume(s)

£1.1002

42,800

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

90,744

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.1002

42,800

 £47,088.56

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Berendji

2

Reason for the notification

a)

Position/status

PDMR (Retail, Operations & Property Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 40,314 shares from the 2017 Deferred Share Bonus Plan.

2. Subsequent sale of 19,016 shares acquired under the DSBP award to cover the tax and NI liability, with 21,298 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

40,314

2. Sale

Price(s)

Volume(s)

£1.1053

19,016

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

40,314

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.1053

19,016

 £21,018.38

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

P Friston

2

Reason for the notification

a)

Position/status

PDMR (International Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 40,314 shares from the 2017 Deferred Share Bonus Plan.

2. Subsequent sale of 19,015 shares acquired under the DSBP award to cover the tax and NI liability, with 21,299 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

40,314

2. Sale

Price(s)

Volume(s)

£1.104

19,015

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

40,314

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.104

19,015

 £20,992.56

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

3. Restricted Share Plan

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Machin

2

Reason for the notification

a)

Position/status

PDMR (Food Managing Director)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

1. Exercise of 39,452 shares from a 2018 award under the Restricted Share Plan.

2. Subsequent sale of 18,609 shares acquired under the RSP award to cover the tax and NI liability, with 20,843 shares retained.

c)

Price(s) and volume(s)

1. Exercise

Price(s)

Volume(s)

Nil cost

39,452

2. Sale

Price(s)

Volume(s)

£1.0988

18,609

d)

Aggregated information

-

Aggregated volume

-

Price

1. Exercise

Price(s)

Volume(s)

Total

Nil cost

39,452

 £0.00

2. Sale

Price(s)

Volume(s)

Total

£1.0988

18,609

 £20,447.56

e)

Date of the transaction

2020-06-23

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDXLFLBQLBBBK
Date   Source Headline
1st Oct 20249:00 amRNSTotal Voting Rights
30th Sep 202412:35 pmRNSDirector/PDMR Shareholding
26th Sep 202410:05 amRNSDirectorate Change
18th Sep 202411:53 amRNSDirector/PDMR Shareholding
2nd Sep 20249:00 amRNSTotal Voting Rights
30th Aug 202410:37 amRNSDirector/PDMR Shareholding
29th Aug 20249:00 amRNSDirector/PDMR Shareholding
20th Aug 202411:05 amRNSDirector/PDMR Shareholding
8th Aug 202411:30 amRNSConfirmation of CFO appointment date
1st Aug 20249:00 amRNSTotal Voting Rights
31st Jul 20249:00 amRNSDirector/PDMR Shareholding
8th Jul 20242:37 pmRNSDirector/PDMR Shareholding
3rd Jul 20244:45 pmRNSDirectorate Change
3rd Jul 20244:11 pmRNSDirector/PDMR Shareholding
2nd Jul 20241:30 pmRNSResult of AGM
1st Jul 20249:00 amRNSTotal Voting Rights
1st Jul 20249:00 amRNSBlock listing Interim Review
28th Jun 20245:55 pmRNSDirector/PDMR Shareholding
27th Jun 20244:51 pmRNSHolding(s) in Company
25th Jun 202411:26 amRNSDirector Declaration
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.